Contineum Therapeutics Inc（CTNM）價格預測CTNMContineum Therapeutics Inc

Alphio's CTNM stock price prediction model matches the current Contineum Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.12 (-0.26%). The 1-week path is $7.96 (-2.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Contineum Therapeutics Inc (CTNM) is currently not a strong buy due to recent negative catalysts, including a failed clinical trial that has impacted investor confidence. The stock is trading at $8.31, significantly below its 52-week high of $17.78, reflecting a 53% drop from that peak. Additionally, the RSI is at 36.49, indicating that the stock is nearing oversold territory but still lacks strong momentum for a rebound. The company has a forward P/E of 0, suggesting uncertainty in future earnings, and while it has a solid cash position of $236.6 million, the recent trial failure raises concerns about the viability of its key drug pipeline.

Contineum Therapeutics Inc (CTNM) last closed at $8.1400003, losing -2.05%. These facts feed the 1-day and 1-week CTNM price prediction above.